September 30, 2016 6:51 PM ET

Healthcare Providers and Services

Company Overview of Good Start Genetics, Inc.

Company Overview

Good Start Genetics, Inc., a molecular diagnostics company, provides genetic screening of inherited diseases. It offers EmbryVu, a preimplantation genetic screening test to improve in vitro fertilization by identifying embryos for the implantation and pregnancy. The company was founded in 2007 and is based in Cambridge, Massachusetts.

237 Putnam Avenue

Cambridge, MA 02139

United States

Founded in 2007

Phone:

617-714-0800

Fax:

617-714-0801

Key Executives for Good Start Genetics, Inc.

Chief Executive Officer, President and Director
Age: 49
Co-Founder and Vice President of Business Development
Co-Founder and Vice President of Research & Technology
Chief Financial Officer and Chief Operating Officer
Age: 40
Chief Commercial Officer
Compensation as of Fiscal Year 2016.

Good Start Genetics, Inc. Key Developments

Good Start Genetics, Inc. Appoints James Frontero as Chief Commercial Officer

Good Start Genetics, Inc. announced the appointment of James (Jim) Frontero to the position of Chief Commercial Officer. In this newly created role, Mr. Frontero will be responsible for leading all of the company's commercial activities as the company expands its commercial footprint to encompass genetic offerings from preconception through early childhood. Mr. Frontero's most recent commercial leadership role was as Senior Vice President of Sales and Commercial Operations at Devicor Medical Products where he was responsible for all commercial activities.

Good Start Genetics, Inc. Appoints Jeffrey Luber as Chief Executive Officer and President

Good Start Genetics, Inc. announced that it has appointed seasoned life sciences industry executive, Jeffrey Luber, to the post of president and chief executive officer (CEO). Luber has also been appointed to the Good Start Genetics Board of Directors. For two decades, Luber has been a life sciences executive in both public and private companies. Prior to his appointment as CEO, Luber served as Good Start Genetics' general counsel and head of corporate development, where he established a number of key relationships and new business models central to the company's growth in expanding markets. Previously, Luber co-founded SynapDx, developer of blood-based technologies for the early detection of autism. Luber also held several executive positions at EXACT Sciences Corporation including, president in 2007 and president and CEO from 2008 -2009.

Good Start Genetics, Inc. Presents at The Leerink Partners 5th Annual Global Healthcare Conference, Feb-10-2016 02:40 PM

Good Start Genetics, Inc. Presents at The Leerink Partners 5th Annual Global Healthcare Conference, Feb-10-2016 02:40 PM. Venue: The Waldorf Astoria, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Good Start Genetics, Inc., please visit www.goodstartgenetics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.